TRML
NASDAQTourmaline Bio Inc.
News25/Ratings9
News · 26 weeks280%
2025-10-262026-04-19
Mix090d
No activity.
Latest news
25 items- SECSEC Form EFFECT filed by Tourmaline Bio Inc.EFFECT - Tourmaline Bio, Inc. (0001827506) (Filer)
- SECSEC Form EFFECT filed by Tourmaline Bio Inc.EFFECT - Tourmaline Bio, Inc. (0001827506) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Tourmaline Bio Inc.SCHEDULE 13G/A - Tourmaline Bio, Inc. (0001827506) (Subject)
- SECSEC Form 15-12G filed by Tourmaline Bio Inc.15-12G - Tourmaline Bio, Inc. (0001827506) (Filer)
- INSIDERSEC Form 4 filed by Director Siegall Clay B4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- INSIDERDirector Mcdade Mark closing all direct ownership in the company (SEC Form 4)4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- INSIDERDirector Kantoff Aaron closing all direct ownership in the company (SEC Form 4)4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- INSIDERDirector Thiara Parvinder closing all direct ownership in the company (SEC Form 4)4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- INSIDERDirector Castelein Caley closing all direct ownership in the company (SEC Form 4)4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- INSIDERDirector Srivastava Sapna closing all direct ownership in the company (SEC Form 4)4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- INSIDERChief Regulatory Officer Johnson Kevin Bruce returned 11,046 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- INSIDERCBO, GC and Secretary Middlekauff W Bradford returned 8,213 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- INSIDERCFO Robinson Ryan F. closing all direct ownership in the company (SEC Form 4)4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- INSIDERCEO Kulkarni Sandeep Chidambar returned 30,387 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- INSIDERChief Technology Officer Jones Susan Dana returned 3,152 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- INSIDERNew insider Novartis Ag claimed ownership of 24,030,382 shares (SEC Form 3)3 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- SECSEC Form S-8 POS filed by Tourmaline Bio Inc.S-8 POS - Tourmaline Bio, Inc. (0001827506) (Filer)
- SECSEC Form S-8 POS filed by Tourmaline Bio Inc.S-8 POS - Tourmaline Bio, Inc. (0001827506) (Filer)
- SECSEC Form S-8 POS filed by Tourmaline Bio Inc.S-8 POS - Tourmaline Bio, Inc. (0001827506) (Filer)
- SECSEC Form S-8 POS filed by Tourmaline Bio Inc.S-8 POS - Tourmaline Bio, Inc. (0001827506) (Filer)
- SECSEC Form S-8 POS filed by Tourmaline Bio Inc.S-8 POS - Tourmaline Bio, Inc. (0001827506) (Filer)
- SECSEC Form S-8 POS filed by Tourmaline Bio Inc.S-8 POS - Tourmaline Bio, Inc. (0001827506) (Filer)
- SECSEC Form POS AM filed by Tourmaline Bio Inc.POS AM - Tourmaline Bio, Inc. (0001827506) (Filer)
- SECSEC Form POS AM filed by Tourmaline Bio Inc.POS AM - Tourmaline Bio, Inc. (0001827506) (Filer)
- SECTourmaline Bio Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Completion of Acquisition or Disposition of Assets, Material Modification to Rights of Security Holders, Leadership Update, Financial Statements and Exhibits8-K - Tourmaline Bio, Inc. (0001827506) (Filer)